Evidence map›Paper›PMID 40069961›Full record

ArticleThe American journal of case reports2025

Thymoma-Induced Severe Biventricular Failure without Myasthenia Gravis: Investigating Tachycardia-Induced Cardiomyopathy.

Roscoe Lim, Stephanie Wiltshire, Megan Barnet, Julia P Low, Samuel Bolitho, Alisa Kane, Andrew Jabbour, Eugene Kotlyar, Christopher Hayward

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roscoe LimDepartment of Cardiology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Stephanie WiltshireDepartment of Cardiology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Megan BarnetSt Vincent's Clinical School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-3243-2716
Julia P LowSt Vincent's Clinical School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Samuel BolithoDepartment of Neurology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Alisa KaneDepartment of Immunology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Andrew JabbourDepartment of Cardiology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Eugene KotlyarDepartment of Cardiology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Christopher HaywardDepartment of Cardiology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-4036-1890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Cardiomyopathy associated with thymoma is thought to be a cardiac manifestations of myasthenia gravis (MG). However, there are case reports of newly diagnosed thymoma presenting with cardiomyopathy without MG, and the mechanism remains unclear. The purpose of this report is to explore tachycardia-induced cardiomyopathy (TIC) as a potential mechanism for cardiomyopathy in thymoma without features of MG. CASE REPORT A 31-year-old man presented with atrial flutter with right bundle branch block and severe biventricular heart failure. Echocardiogram revealed severe left ventricle ejection fraction (LVEF) of 15% with biventricular dilation with impaired systolic function. Computer tomography coronary angiography demonstrated normal coronary artery disease. Cardiac magnetic resonance imaging showed normal T1 and T2 mapping, without inflammation or edema. A large anterior mediastinal mass was found on computer tomography chest. Mediastinal mass biopsy identified type B3 thymoma (WHO classification) with dual population of large, uniform epithelial thymic cells and immature T cell phenotype. Acetylcholine receptor antibody was positive without clinical features of MG and hypogammaglobulinemia indicating Good syndrome. He was treated with antiarrhythmic and heart failure pharmacotherapy, carboplatin and paclitaxel, and intravenous immunoglobulin. He demonstrated reversible heart failure following abolishment of tachyarrhythmia, consistent with tachycardia-induced cardiomyopathy. CONCLUSIONS We report a rare case of a newly diagnosed thymoma and Good syndrome without clinical features of MG presenting with tachyarrhythmia and severe biventricular failure. The reversibility of the cardiomyopathy following abortion of tachyarrhythmia with treatment highlights TIC as a potential cause.

Indexed as

CardiomyopathiesHeart FailureTachycardiaThymomaThymus NeoplasmsAdultEchocardiographyHumansMaleMyasthenia Gravis

Identifiers

PMID40069961
PMCPMC11918452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.